Iceland· IS-721516
Haiprex
A methenamine product containing methenaminum inn hippúrat, registered in Iceland by Viatris ApS. The same ATC class is registered in 9 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Methenamine is registered in 9 of 19 countries.
Countries holding a registration under ATC J01XX05 (methenamine), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 4 of them publish a price we can compare per daily dose
Methenamine · ATC J01XX05
9 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Methenaminum INN hippúrat
- Manufacturer
- Viatris ApS
- Country
- Iceland (IS)
- ATC code
- J01XX05
- ATC class
- Methenamine
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean994005100 stk x1 glasISK 15328
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for methenamine.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methenamine · interactions on record
22 records
- 4 severe
- 18 moderate
Most severe, free to view
- SulfasalazineA07EC01severe
- SulfamethizoleB05CA04severe
- SulfamethizoleJ01EB02severe
- SulfasalazinM01CX02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01XX05
Methenamine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8241a405-8d4b-4d3c-b81e-2599cfe13153 GET /v1/drugs/8241a405-8d4b-4d3c-b81e-2599cfe13153?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tafla",
"source": "lyfjastofnun",
"atc_raw": "J01XX05",
"marketed": true,
"strength": "1 g",
"ma_number": "721516",
"substance": "Methenaminum INN hippúrat",
"other_info": null,
"legal_status": "(L) Ekki lyfseðilsskylt",
"ma_issued_serial": "26549"
}See everything about methenamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.